EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition  via  Wnt/β-catenin signaling in endometrial carcinoma

Tingting Yang; Huilin Zhang; Haifeng Qiu; Bilan Li; Jingyun Wang; Guiqiang Du; Xiaoping Wan

doi:10.18632/oncotarget.8263

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma

Tingting Yang _, Huilin Zhang, Haifeng Qiu, Bilan Li, Jingyun Wang, Guiqiang Du and Xiaoping Wan

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:25712-25725. https://doi.org/10.18632/oncotarget.8263

Metrics: PDF 2872 views | HTML 1948 views | ?

Abstract

Tingting Yang1,3,*, Huilin Zhang1,4,*, Haifeng Qiu1, Bilan Li2, Jingyun Wang2, Guiqiang Du2, Chune Ren3, Xiaoping Wan1,2

1Department of Obstetrics and Gynecology, Shanghai First People’s Hospital Affiliated to Nanjing Medical University, Nanjing, China

2Department of Obstetrics and Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China

3Center for Reproductive Medicine, Affiliated Hospital of Weifang Medical University, Weifang, China

4Department of Gynecology and Obstetrics, Nanjing Maternal and Children Care Hospital Affiliated to Nanjing Medical University, Nanjing, China

*These authors have contributed equally to this work

Correspondence to:

Xiaoping Wan, e-mail: [email protected]

Keywords: EFEMP1, endometrial carcinoma (EC), estrogen receptor α (ERα), epithelial-mesenchymal transition (EMT), Wnt/β-catenin

Received: December 09, 2015 Accepted: March 02, 2016 Published: March 22, 2016

ABSTRACT

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) acted as a tumor suppressor in endometrial carcinoma (EC). However, the correlation between EFEMP1 and estrogen is unknown. Here, we reported that the expression of EFEMP1 was conversely associated with ERα in endometrial carcinoma tissues. In endometrial carcinoma cells, estrogen/ERα signaling significantly suppressed the expression of EFEMP1. Moreover, chromatin immunoprecipitation (CHIP) and dual-luciferase reporter assays demonstrate that estrogen/ERα bound to the estrogen response element (ERE) located in EFEMP1 promoter and repressed its expression. Besides, in vitro and in vivo, EFEMP1 could remarkably suppress the expression of epithelial-mesenchymal transition (EMT) markers such as Vimentin, Snail and the Wnt/β-catenin target genes like Cyclin-D1 and c-Myc, which could be restored when EFEMP1 was silenced. In addition, XAV93920 (the inhibitor of the Wnt/β-catenin pathway) blocked and LiCl (the activator of the Wnt/β-catenin pathway) enhanced the effect of EFEMP1 on EMT. In conclusion, we demonstrated that estrogen/ERα signal suppresses EFEMP1. Besides, EFEMP1 inhibits EMT via interfering the Wnt/β-catenin signaling.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8263

Publication Alerts

Research Papers:

EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma

Abstract